This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
NIAID Radiation and Nuclear Countermeasures Program (RNCP) gets approval for new Research Initiative Concepts at May 2015 Council Meeting.
NSBRI Research and Technology Development to Support Crew Health and Performance in Space Exploration Missions: “Protect Healthy-Tissues from Ionizing Radiation by Accelerating the Testing of Potential Countermeasures in Human Clinical Research Trials”. Step 1 Proposal due Sept. 4, 2015.
PHS2016-1: NIH/NCI SBIR Topic 345: Predictive Biomarkers of Adverse Reactions to Radiation Treatment. Due Date – Oct. 16, 2015.
PHS2016-1: NIH/NCI SBIR Topic 346: Molecularly Targeted Radiation Therapy For Cancer Treatment Due Date – Oct. 16, 2015.
Media Availability: NIH-Funded Research Leads to Approval of Drug for Acute Radiation Injury—April 21, 2015
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated August 06, 2015